U
SpyGlass Pharma, Inc. SGP
$24.48 $0.341.41% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2025 12/31/2024
Total Cash And Short-Term Investments 107.44M 16.27M
Total Receivables 431.00K 423.00K
Inventory -- --
Prepaid Expenses 901.00K 715.00K
Finance Division Loans and Leases Current -- --
Total Finance Division Other Current Assets -- --
Other Current Assets -- --
Total Current Assets 108.77M 17.41M

Total Current Assets 108.77M 17.41M
Net Property, Plant & Equipment 3.89M 5.46M
Long-term Investments -- --
Goodwill -- --
Total Other Intangibles -- --
Finance Div Loans & Leases LT -- --
Total Finance Div Other LT Assets -- --
Total Other Assets 3.21M 453.00K
Total Assets 115.87M 23.32M

Total Accounts Payable 2.70M 1.98M
Total Accrued Expenses 2.18M 1.28M
Short-term Debt -- --
Current Portion of Long-Term Debt/Capital Leases -- --
Finance Division Debt Current -- 442.00K
Total Finance Division Other Current Liabilities 3.71M 4.09M
Total Other Current Liabilities 3.71M 4.09M
Total Current Liabilities 8.58M 7.79M

Total Current Liabilities 8.58M 7.79M
Long-Term Debt -- --
Short-term Debt -- --
Capital Leases 1.58M 3.46M
Finance Division Debt Non Current -- --
Total Finance Division Other Non Current Liabilities -- --
Total Other Liabilities -- --
Total Liabilities 10.17M 11.25M

Common Stock & APIC 5.89M 4.39M
Retained Earnings -104.73M -64.86M
Treasury Stock & Other -- --
Total Common Equity -98.84M -60.47M

Preferred Stock Redeemable -- --
Preferred Stock Non Redeemable -- --
Preferred Stock Convertible 204.54M 72.55M
Preferred Stock, Others -- --
Total Preferred Equity 204.54M 72.55M

Total Common Equity -98.84M -60.47M
Total Preferred Equity 204.54M 72.55M
Total Minority Interest -- --
Total Equity 105.70M 12.07M